Coxient Filmuhúðuð tafla 90 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

coxient filmuhúðuð tafla 90 mg

zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 90 mg

Rizatriptan Sumar Pharma (Rizatriptan ratiopharm) Munndreifitafla 10 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

rizatriptan sumar pharma (rizatriptan ratiopharm) munndreifitafla 10 mg

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg

Solifenacin Alvogen 10 mg Filmuhúðuð tafla (Solifenacin Portfarma) Filmuhúðuð tafla 10 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

solifenacin alvogen 10 mg filmuhúðuð tafla (solifenacin portfarma) filmuhúðuð tafla 10 mg

alvogen ehf. - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg

Ibuprofen Zentiva Filmuhúðuð tafla 600 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

ibuprofen zentiva filmuhúðuð tafla 600 mg

zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 600 mg

Ibetin Filmuhúðuð tafla 400 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

ibetin filmuhúðuð tafla 400 mg

zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 400 mg

Ibuprofen Zentiva Filmuhúðuð tafla 400 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

ibuprofen zentiva filmuhúðuð tafla 400 mg

zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 400 mg

Mepsevii European Union - Icelandic - EMA (European Medicines Agency)

mepsevii

ultragenyx germany gmbh - vestronidase alfa - mucopolysaccharidosis vii - ensím - mepsevii er ætlað fyrir meðferð ekki taugakerfi af mucopolysaccharidosis vii (Þingmenn vii; lúmski heilkenni).

Tukysa European Union - Icelandic - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Æxlishemjandi lyf - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Evkeeza European Union - Icelandic - EMA (European Medicines Agency)

evkeeza

ultragenyx germany gmbh - evinacumab - kólesterólhækkun - lipid breytandi lyf - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

Tevimbra European Union - Icelandic - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Æxlishemjandi lyf - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.